Dividend1 Aug 2026, 11:00 pm
Jubilant Pharmova: TDS on Final Dividend for FY26
AI Summary
Jubilant Pharmova Ltd has informed shareholders about the deduction of tax at source (TDS) on the proposed Final Dividend for FY 2025-26. The dividend of ₹5 per equity share is subject to shareholder approval at the upcoming AGM. The record date for eligibility is July 24, 2026. The company will withhold taxes as per the Income-tax Act, 2025. For resident individual shareholders, TDS is not applicable if the total dividend does not exceed ₹10,000. Higher rates (10% or 20%) apply based on PAN status and linkage. Shareholders are urged to update their PAN details by August 14, 2026, to ensure correct TDS application or avail lower/nil deduction certificates.
Key Highlights
- Jubilant Pharmova recommends ₹5 per share final dividend for FY26.
- TDS will be deducted on the dividend as per Income-Tax Act, 2025.
- No TDS for resident individuals if dividend is ₹10,000 or less.
- PAN update by August 14, 2026, is crucial for correct TDS.
- Shareholders can submit lower/nil tax deduction certificates.
Price Impact
More from JUBLPHARMA